Answers are grounded in this paper and cite their sources.
It has been asserted by not a few authors in recent years that the spleen is enlarged in mice bearing, or immune to propagable tumors; and implied, if not actually stated, that the hypertrophy is an expression of the important part taken by this organ in the elaboration of protective substances of all sorts. This involves the subsidiary assumption that immunity to transplantable new growths is due to some sort of antibody, though it is admitted that no evidence of the presence of any antibody similar to those active against the various bacteria has yet been advanced. Cimoroni (1), Brancati (2), Price-Jones (3), and Mazza (4), have all recorded enlarged spleens in mice or rats bearing transplantable tumors. Thus Brancati wrote that whereas in the normal animal the relation of spleen weight to body weight is as 1 to 169, in those with tumors it is as 1 to 60. Mazza asserted that the spleen is enlarged in rats developing small multiple nodules after intraperitoneal inoculation, but of normal size in those with a single large growth. Price-Jones found that the two heaviest spleens in his series occurred in the two mice with the largest tumors, and that there was about twice as much myeloid activity going on in the spleens of cancer mice as in those of normal ones. In a later paper (5) he described a group of rats bearing transplantable sarcoma. The spleen had increased 56 per cent in weight in rats with non-ulcerated tumors, 115 per cent in the animals whose tumors had undergone slight ulceration, and 130 per cent in those with extensive ulceration. As there were only two rats with non-ulcerated growths, he left open the question whether the spleen is enlarged in animals bearing non-ulcerated neoplasms.
No takes yet. Share an insight, caveat, or question.
William H. Woglom (1919) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: